Drug Discovery and development AI leadership

Tycho | AI Leadership in Drug Discovery & Development

Investment & Founding Assessment

• Technical Due Diligence: Evaluate AI platforms, biological hypotheses, and underlying computational models.

• Opportunity Scoping: Stress-test target validation strategies, data infrastructure, and wet-lab integration feasibility for high-conviction dealmaking.

Contractor & Fractional Leadership

• Interim Executive Roles: Serve as embedded CSO, SAB advisor, or TechBio lead to align computational roadmaps with discovery milestones.

• Bespoke AI Pipelines: Deploy custom molecular generation workflows (proteins, peptides, antibodies) and automated laboratory data systems.

Core Differentiator

• Bridge two decades of hands-on drug discovery experience with modern machine learning—delivering tailored, de-risked solutions without platform lock-in.